Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07071883 · ClinicalTrials.gov registry record · NA

Group Activities to Support Addiction Recovery

A NA study of Addiction and Substance Use Disorders (SUD), sponsored by University of Nebraska.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07071883: Active NA study of Addiction and Substance Use Disorders (SUD), sponsored by University of Nebraska.

NCT07071883 is a NA study of Addiction and Substance Use Disorders (SUD) that is active but no longer recruiting, run by University of Nebraska. The registered enrollment target is 100 participants, below the 687-participant average among 16 other Addiction trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07071883, a NA study of Addiction and Substance Use Disorders (SUD), is active but no longer recruiting, sponsored by University of Nebraska.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to pilot the use of Holotropic Breathwork (HB) for individuals seeking to recover from addiction. The study will have two arms: A--for individuals in residential treatment programs, B--for individuals living in the community. Arm A will use a cluster randomized intervention, providing HB for individuals at two facilities and a Multiple Modality (MM) intervention (soundbath, meditation, and a film/discussion) at a third facility. In Arm B, we seek to measure the feasibility, acceptability, and preliminary impact of HB among people with addiction living in the community. Arm B will be comprised of a single group and participants in this group will receive the same HB experience as the participants in the Arm A HB group. HB is the practice of self-directed hyperventilation while lying down with the support of a selected music set and trained facilitators. Participants may experience an expanded state of consciousness with altered cognition, perception, and emotions. HB has been associated improved mental functioning among the general public and people in addiction treatment, but has never been evaluated in a controlled trial. Inclusion criteria consist of being 19 years of age or older and having met criteria for a substance use disorder within the past five years. Additional inclusion criteria for participants in arm A include being in a residential addiction treatment program at CenterPointe or the Bridge. Exclusion criteria form the Arm A HB group and the Arm B group include having been diagnosed with a bipolar disorder or a psychotic disorder or having had psychotic symptoms at any point in life, diagnosed with a cardiac condition, received care for a cardiac condition, or have current cardiac symptoms, ever diagnosed with a seizure disorder, current uncontrolled hypertension (140/90 or greater), diagnosed with glaucoma or retinal detachment, recent surgeries, or currently pregnant. Four breathwork sessions will be held: two at the UNM

Primary Outcome

Timeline Followback (TLFB)

Interventions

  • BEHAVIORAL Holotropic breathwork
  • BEHAVIORAL Multiple modality

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Lincoln

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-08-27
Est. Completion 2026-03-14
Phase NA
University of Nebraska

407 total trials

What the registry record for NCT07071883 still lists

NCT07071883 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 687-participant average among 16 other Addiction trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Addiction appearing as the primary indexed condition, and to 2 interventions - of which Holotropic breathwork is the first listed.

NCT07071883 reports a single indexed study location in Nebraska.

Frequently Asked Questions

What is clinical trial NCT07071883 about?

NCT07071883 is a clinical study titled "Group Activities to Support Addiction Recovery". The purpose of this study is to pilot the use of Holotropic Breathwork (HB) for individuals seeking to recover from addiction. The study will have two arms: A--for individuals in residential treatment programs, B--for individuals living in the community. Arm A will use a cluster randomized intervent...

What is the current status of trial NCT07071883?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-08-27. Estimated completion is 2026-03-14.

What conditions does trial NCT07071883 study?

This clinical trial studies the following conditions: Addiction, Substance Use Disorders (SUD).

What interventions are being tested in trial NCT07071883?

The interventions under investigation include: Holotropic breathwork (BEHAVIORAL), Multiple modality (BEHAVIORAL).

Who is sponsoring clinical trial NCT07071883?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07071883 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Addiction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07071883's enrollment target sits among peer trials

100 9th of 16 higher than 8 of 16 other Addiction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Addiction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07071883, the US trial registry maintained by the National Library of Medicine. NCT07071883 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.